Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 17 Source: CRO
- €168.2 million turnover
-
€14.8 million
profit - 182 employees
-
31st Dec 16 Source: CRO
- €245.1 million turnover
-
€80.2 million
profit - 177 employees
- 6 more years available »
Ranking
By Turnover
(€168.2 million)- 351st in Top Companies
- 38th in Pharma
By Employees
(182)- 599th in Top Companies
- 56th in Pharma
-
- 182
- €168.2 million
Employees
- Padraig Somers CEO/Managing Director
Latest News
- 7:03pm Paddy McKillen snr gets €15.2m dividend from management company
- 6:42pm European stocks extend gains as US jobs news boosts sentiment
- 6:39pm Eddie Stobart gets lifeline as shareholders back rescue deal
- 6:01pm Twins ‘a Happy Pear’ as revenues rise 22%
- 5:41pm Digital advertising body ‘remains concerned’ about Maximum Media incident